SEC Form 4 · accession 0000899243-16-015437
Baxalta Inc · BXLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D. Meek
Officer — EVP and President, Oncology
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per shareF1 | Mar 3, 2016 | A | 27,976 | — | A | 52,514 | D | |
| Common Stock, par value $0.01 per shareF2 | Mar 3, 2016 | F | 928 | $39.30 | D | 51,586 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person received a grant of 27,976 restricted stock units which will vest in three equal installments beginning on the first anniversary of the grant date.
- F2Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015.